COINOTAG News reports that Nasdaq-listed Mangoceuticals has formed a strategic partnership with Cube Group to establish the subsidiary Mango DAT, aimed at advancing a $1 billion Cryptocurrency Treasury (DAT) program with a primary emphasis on SOL exposure and disciplined governance.
Financing for the initiative is described as being raised through an ATM financing plan alongside a sale of common stock, a structure intended to scale capital while preserving balance-sheet flexibility for phased deployment within the DAT framework.
In addition, Mangoceuticals has filed a MULTI-DAT trademark application with the USPTO to support a family of digital-asset and DeFi plans, signaling branding alignment and regulatory groundwork for the forthcoming strategy.